<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1395437</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Exploring the impact of colostrum supplementation on athletes: a comprehensive analysis of clinical trials and diverse properties</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yal&#xe7;&#x131;nta&#x15f;</surname><given-names>Yal&#xe7;&#x131;n Mert</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2672985"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baydemir</surname><given-names>Bar&#x131;&#x15f;</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1589564"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duman</surname><given-names>Hatice</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1182353"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eker</surname><given-names>Furkan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1911559"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bayraktar Bi&#xe7;en</surname><given-names>Ay&#x15f;e</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ert&#xfc;rk</surname><given-names>Melih</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1195395"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Karav</surname><given-names>Sercan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/426710"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University</institution>, <addr-line>Canakkale</addr-line>, <country>T&#xfc;rkiye</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Coaching Education, Canakkale Onsekiz Mart University</institution>, <addr-line>Canakkale</addr-line>, <country>T&#xfc;rkiye</country></aff>
<aff id="aff3"><sup>3</sup><institution>Uluova Dairy</institution>, <addr-line>&#xc7;anakkale</addr-line>, <country>T&#xfc;rkiye</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Julio Villena, CONICET Reference Centre for Lactobacilli (CERELA), Argentina</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ian Antheni Myles, National Institutes of Health (NIH), United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Sercan Karav, <email xlink:href="mailto:sercankarav@comu.edu.tr">sercankarav@comu.edu.tr</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>10</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1395437</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>04</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Yal&#xe7;&#x131;nta&#x15f;, Baydemir, Duman, Eker, Bayraktar Bi&#xe7;en, Ert&#xfc;rk and Karav</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Yal&#xe7;&#x131;nta&#x15f;, Baydemir, Duman, Eker, Bayraktar Bi&#xe7;en, Ert&#xfc;rk and Karav</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Colostrum, an invaluable food produced by mammals during the postnatal period, contains important bioactive components. It is a valuable therapeutic substance that can be used to treat a variety of disorders, in addition to its primary function of providing passive immunity to newborns. Undoubtedly, a strong dedication to intense effort and demanding training schedules is necessary to succeed in today&#x2019;s sports environment. Peak physical fitness, strategic skill development, and mental toughness are highly valued in the environments in which athletes compete. However, the inherent difficulties brought about by athletes&#x2019; intense schedules are matched with the demanding character of modern sports. The intensity of athletic activity frequently provides little time for sufficient relaxation, nutritional preparation, and overall recovery, which can contribute to mental and physical tiredness. Athletes need to develop all-encompassing strategies to overcome these obstacles. These strategies should prioritize self-care and recovery in addition to maximizing training efficiency. The bioactive components of colostrum bring forth various therapeutic effects against the challenges experienced by athletes; including diarrhea, upper respiratory tract infections, muscle injuries, intestinal disorders, etc. This review examined the different therapeutic effects of the bioactive components of colostrum on athletes, the effect of the use of colostrum as a whole on the performance of athletes, and the clinical research conducted in this field. While the majority of studies report positive effects of colostrum, further research is needed.</p>
</abstract>
<kwd-group>
<kwd> colostrum</kwd>
<kwd>athletes</kwd>
<kwd>sport nutrition</kwd>
<kwd>disorders</kwd>
<kwd>supplementation</kwd>
<kwd>health and immunity</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="70"/>
<page-count count="9"/>
<word-count count="4168"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Nutritional Immunology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Colostrum is a distinctive fluid secreted by mammals in the postnatal period that provides a vital source of nutrients for nursing young. This special fluid, which stands out with its rich nutrient composition, has the potential to improve performance, gaining a remarkable place in athlete-oriented research (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Research in the field of sports underlines the capacity of colostrum to have positive results for athletes (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>Colostrum contains many biologically active substances. Key components include immunoglobulins, growth factors, lactoferrin(Lf), vitamins, and minerals. These components have the potential to influence athletes&#x2019; training performance and recovery processes (<xref ref-type="bibr" rid="B5">5</xref>). Colostrum contains growth factors, and in athletes, these properties can support muscle development and provide faster recovery. Additionally, thanks to immunoglobulins, it can strengthen the immune system and protect against diseases that may occur depending on the frequency of training (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>In recent years, the increased emphasis on sports compared to the past has not only enhanced the pleasure of watching but has also introduced significant challenges. Achieving high effort levels in sports necessitates intensive training, which, over time, becomes a stimulant for performance. However, such rigorous training is also highly susceptible to causing injuries in athletes. Immune suppression and excessive muscle strain contribute to an increased risk of injuries.</p>
<p>At this juncture, Bovine Colostrum (BC) emerges as a crucial consideration for consumption, playing a vital role in preventing injuries and strengthening muscles. BC positively influences muscle and bone development due to the significant amount of growth factors it possesses. Moreover, in cases of potential muscle injuries or severe disability, BC can expedite the treatment process, thanks to its growth factors and other components. It accelerates tissue repair in damaged areas by increasing cell proliferation, preventing athletes from being incapacitated during training and competitions (<xref ref-type="bibr" rid="B7">7</xref>). BC consumption offers substantial support against such situations, recognizing that injuries not only harm athletes but also have enduring negative effects on their long-term fitness charts.</p>
<p>According to research, heavy training may result in immunosuppression. Athletes who have reached high fitness levels need to work constantly to maintain their stability, but diseases caused by immunosuppression may affect this stability and cause poor form (<xref ref-type="bibr" rid="B8">8</xref>). The bioactive components contained in BC, which will be mentioned in this review, have antimicrobial and antiviral properties with the potential to not only shorten the treatment process but also prevent exposure to diseases after training by providing passive immunity. In addition, BC regulates intestinal permeability with the bioactive components it contains, selectively has positive effects on the microbiota, and provides significant protection against intestinal disorders, which is shown in <xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>. Current research on the use of BC in athletes suggests that this natural fluid may favorably affect sports performance and recovery (<xref ref-type="bibr" rid="B12">12</xref>). However, it needs to be emphasized that more extensive research is required. Specific dosage and usage recommendations for the consumption of BC in athletes need to be standardized. It is thought that this review will guide the reporting of positive or negative results in the performance of athletes with the use of BC and current research.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Effects of colostrum on athletes. The consumption of BC can support immune regulatory effects, accelerate the healing process of injuries, selectively promote microbiota growth, enhance bone health alongside muscle development, and prevent inflammation in the intestines. These features, corroborated by clinical research on athletes, could be further explored through additional studies and might yield more pronounced positive effects in the long term if BC (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>&#x2013;<xref ref-type="bibr" rid="B11">11</xref>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1395437-g001.tif"/>
</fig>
</sec>
<sec id="s2">
<label>2</label>
<title>Bioactive components of colostrum and their effects on athletes</title>
<p>In today&#x2019;s sports world, high intensity is notably prominent, subjecting athletes to rigorous training to achieve peak performance. Despite the success that heavy and intense training brings, a significant threat looms: the &#x2018;Open Window.&#x2019; This condition refers to immune suppression following prolonged and intense exercise (<xref ref-type="bibr" rid="B13">13</xref>), leading to upper respiratory tract infections (URTI) that can pose serious challenges for athletes. While URTI may not appear severe, its potential to impact athletes&#x2019; performance and result in setbacks during competitions should not be underestimated (<xref ref-type="bibr" rid="B9">9</xref>). BC consumption manifests various positive outcomes among different target groups, particularly demonstrating protective effects on athletes. For instance, BC serves as a crucial supplement against diseases due to its immune-supporting components, ensuring stability by preventing performance fluctuations linked to illnesses. The potential of BC to directly influence immunity, attributed to the presence of immunoglobulins, was highlighted in a study showing that even modest levels of BC consumption significantly affected peripheral blood neutrophil phagocytic activity (<xref ref-type="bibr" rid="B14">14</xref>). Building on these findings, a study on athletes revealed that post-training BC consumption increased immunoglobulin levels in the body (<xref ref-type="bibr" rid="B1">1</xref>). It is evident that BC consumption is associated with a reduced risk of URTI and other ailments in athletes, underscoring its critical role in disease prevention.</p>
<p>On the other hand, BC contains a significant amount of growth factors. More importantly, BC is the only natural source that contains two main growth factors [Transforming growth factors (TGF) and Insulin-like growth factors (IGF)] (<xref ref-type="bibr" rid="B15">15</xref>). Growth factors have different functions in the body, but they are of great importance from the athlete&#x2019;s perspective. They are playing a key role, especially in muscle injuries and open wounds, which are some of the worst situations that can happen to athletes. They support cell proliferation, signaling, and tissue repair (<xref ref-type="bibr" rid="B7">7</xref>) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). Thanks to these features, they can enhance the healing process of the damaged area in cases of injury during training or sports. Growth factors can also play an immune-supporting role against pathogens entering the body and have a positive effect on increasing the number of immunoglobulins (<xref ref-type="bibr" rid="B27">27</xref>). Barrientos et&#xa0;al. (2008) has supported the idea that growth factors can significantly contribute to the body&#x2019;s bone and muscle development during the training process (<xref ref-type="bibr" rid="B7">7</xref>). They enhance the active development process of the muscles in the area where muscle damage occurs. It has also been stated that some growth factors are good for intestinal health and have positive effects on the microbiota (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). Studies have shown that oral consumption of TGF-&#x3b2; found in colostrum increases Immunoglobulin A (IgA) production in newborns and reduces gut inflammation in premature piglets. These findings are consistent with those from cell culture studies and suggest that orally administered growth factors may have similar effects in living organisms, particularly on gut health and the immune system (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). However, further research is needed to determine whether the effectiveness of their positive effects on the body varies depending on the route of consumption.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Bioactive components in colostrum and their potential effects on athletes.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Component</th>
<th valign="top" align="center">Concentration (g/L)</th>
<th valign="top" align="center">Effect</th>
<th valign="top" align="center">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Protein</td>
<td valign="top" align="center">250</td>
<td valign="top" align="left">Increase development and repair in the body.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Casein</td>
<td valign="top" align="center">26</td>
<td valign="top" align="left">Decreasing blood pressure, minimizing the occurrence of blood clot formation and aiding digestion in the stomach.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Immunoglobulin</td>
<td valign="top" align="center">20-150</td>
<td valign="top" align="left">Prevents post-exercise illnesses by supporting the athlete&#x2019;s immunity against post-exercise immune suppression.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Lactoferrin</td>
<td valign="top" align="center">1.5</td>
<td valign="top" align="left">Antimicrobial, antiviral and antifungal properties</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Growth Factors</td>
<td valign="top" align="center">50 &#x3bc;g to &#x2013;40&#x2009;mg/L</td>
<td valign="top" align="left">Cell proliferation, faster healing of wounds and muscle development.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Lactoperoxidase</td>
<td valign="top" align="center">0.02</td>
<td valign="top" align="left">Anti-pathogenic effect and contributes to immunity.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Oligosaccharides</td>
<td valign="top" align="center">0.7-1.2</td>
<td valign="top" align="left">Selective growth of microbiome.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B26">26</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Clinical applications of colostrum on athletes.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Target group</th>
<th valign="top" align="left">Dose &amp; duration</th>
<th valign="top" align="left">Study Design</th>
<th valign="top" align="left">&#x2003;Effect</th>
<th valign="top" align="left">Reference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Athletes</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Randomized controlled and double-blind, placebo-controlled study design.<break/>Placebo: Whey protein (20g/day in powder form)</td>
<td valign="top" align="left">Achieved a lean mass gain of +1.49 kg, indicating the potential for increased lean mass in active individuals.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B10">10</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Sprinters and jumpers</bold>
</td>
<td valign="top" align="left">125ml BC/day, 8 days of strength and speed training, 13 days apart.</td>
<td valign="top" align="left">Randomized, double-blind, crossover study design.<break/>Placebo: Whey protein (125 ml/day in liquid form)</td>
<td valign="top" align="left">Increased IGF-I levels in athletes (&#x2248; +5 nmol/l in BC group, &#x2248; -4 nmol/l in placebo), promoting muscle growth and anabolic effects.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>35 elite field hockey players</bold>
</td>
<td valign="top" align="left">60 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Double-blind, randomized, placebo-controlled study design.<break/>Placebo: Whey protein (60g/day in powder form)</td>
<td valign="top" align="left">Enhanced elite field hockey players&#x2019; sprint and jump performance. Colostrum supplementation may enhance sprint performance by 2.3% more than whey supplementation.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>51 athletes</bold>
</td>
<td valign="top" align="left">60 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Randomized, double-blind, placebo-controlled parallel study design.<break/>Placebo: Whey protein (60g/day in powder form)</td>
<td valign="top" align="left">Vertical jump (7370 to 7237 W) and cycle power (1400 to 1311 W) was higher in the&#x2003;BC by 1.5% and 2.3% respectively&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B35">35</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>42 cyclists</bold>
</td>
<td valign="top" align="left">20g BC + 40g whey protein, or 60g BC or WPC (placebo). 8 weeks.</td>
<td valign="top" align="left">Randomized, double-blind, placebo-controlled study design.<break/>Placebo: Whey protein concentration (60g/day in powder form)</td>
<td valign="top" align="left">The cyclists improved their performance ride time by 134 (20g) and 158 (60g) seconds, when compared to the placebo group which is 37 seconds.&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B36">36</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>29 highly trained road cyclists</bold>
</td>
<td valign="top" align="left">60 g/day<break/>Total: 8 week</td>
<td valign="top" align="left">Double-blind and placebo-controlled study design.<break/>Placebo: Whey protein (10g/day in powder form)</td>
<td valign="top" align="left">Enhanced recovery, potentially increasing performance by up to 5.2% after 8 weeks.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B37">37</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>13 elite rowers</bold>
</td>
<td valign="top" align="left">60 g BC/day<break/>Total: 9 weeks</td>
<td valign="top" align="left">Randomized, double-blind, placebo-controlled study design.<break/>Placebo: Whey protein (10g/day in powder form)</td>
<td valign="top" align="left">Improved blood buffer capacity (BC group &#x2248; 40, compared to placebo &#x2248; 33, in slykes unit), but did not enhance performance significantly.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B38">38</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>16 athletes</bold>
</td>
<td valign="top" align="left">500 mg BC/day<break/>Total: 20 days</td>
<td valign="top" align="left">Double-blind and placebo-controlled study design.<break/>Placebo: Whey protein (500mg/day in powder form)</td>
<td valign="top" align="left">%75 of the BC group (<xref ref-type="bibr" rid="B6">6</xref>) showed&#x2003;reduced intestinal permeability.&#x2003;Meanwhile 62.5% of the placebo group (<xref ref-type="bibr" rid="B5">5</xref>) experienced infections.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B39">39</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>25 soccer players</bold>
</td>
<td valign="top" align="left">3.2 g BC/day<break/>Total: 6 weeks</td>
<td valign="top" align="left">Double-blind, randomized, placebo-controlled study design.<break/>Placebo: Whey protein (3.2g/day in capsule form)</td>
<td valign="top" align="left">Enhanced recovery after intense exercise, affecting biochemical parameters.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>12 individuals</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 14 days</td>
<td valign="top" align="left">Double-blind, placebo-controlled, crossover study design.<break/>Placebo: Isoenergetic and isomacronutrient milk protein concentrate (20g/day in powder form)</td>
<td valign="top" align="left">Placebo group showed higher increase in cell damage marker (I-FABP) than BC group, 194% to 134%.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B41">41</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>12 athletes</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 14 days</td>
<td valign="top" align="left">Double-blind, placebo-controlled, crossover study design.<break/>Placebo: Isoenergetic and isomacronutrient milk protein concentrate (20g/day in powder form)</td>
<td valign="top" align="left">Placebo group showed higher Intestinal permeability increase (2.5-fold) when compared to BC group 80%)<break/>Reduced exercise-induced intestinal permeability and enhanced performance while preventing heat stroke.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>20 athletes</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 4 weeks</td>
<td valign="top" align="left">Randomized, double-blind, parallel study design.<break/>Placebo: Isoenergetic and isomacronutrient milk protein concentrate (20g/day in powder form)</td>
<td valign="top" align="left">BC supplementation demonstrated significant effects on exercise-induced changes in innate immunity compared to the placebo group. Four-week BC supplementation countered exercise-induced immunosuppression, enhancing host defense.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>35 distance runners</bold>
</td>
<td valign="top" align="left">10 g BC/day<break/>Total: 12 weeks</td>
<td valign="top" align="left">Randomized, double-blind, placebo-controlled study design.<break/>Placebo: Maltodextrin blend with skim milk (250ml/day in liquid form)</td>
<td valign="top" align="left">Increased s-IgA levels (79%)&#x2003;, potentially reducing infections in athletes.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B44">44</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>8 healthy individuals</bold>
</td>
<td valign="top" align="left">60 microgram/kg<break/>Total: 2-4h (Has repeated 6 months later)</td>
<td valign="top" align="left">Crossover, randomized, double-blind study design.</td>
<td valign="top" align="left">Improved heart function, increased stroke volume (14%), and cardiac output (18%) while minimally affecting heart rate and blood pressure.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>35 healthy individuals</bold>
</td>
<td valign="top" align="left">60 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Double-blind, placebo-controlled, parallel study design.<break/>Placebo: Whey protein (60g/day in powder form)</td>
<td valign="top" align="left">The BC group has experienced a significant increase in arm circumference (2.3%) and cross-sectional area (4.2%) compared to whey protein (WP), primarily due to a 5.5% increase in skin and subcutaneous fat (SSF).</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>28 soccer players</bold>
</td>
<td valign="top" align="left">3.2 g BC/day<break/>Total: 6 months</td>
<td valign="top" align="left">Double-blind, placebo-controlled crossover study design.<break/>Placebo: Milk (3.2g/day in powder form)</td>
<td valign="top" align="left">BC supplementation significantly increased immunoglobulin G (IgG) by up to 94% and reduced inflammatory markers (IL-10, TNF-&#x3b1;) after exercise compared to placebo.&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>27 basketball players</bold>
</td>
<td valign="top" align="left">3.2 g BC/day<break/>Total: 24 weeks</td>
<td valign="top" align="left">Randomized, parallel, placebo-controlled study design.<break/>Placebo: Milk (3.2g/day in capsule form)</td>
<td valign="top" align="left">There were no notable impacts on the dynamics of immune system function indicators.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>9 athletes</bold>
</td>
<td valign="top" align="left">No dose information<break/>Total: 10 days</td>
<td valign="top" align="left">Crossover, double-blind and placebo-controlled study design.<break/>Placebo: Skim milk(25g/day in powder form)</td>
<td valign="top" align="left">When compared to skim milk powder, it did not alter any post-exercise immune variables.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B49">49</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>20 trained athletes</bold>
</td>
<td valign="top" align="left">3.2 g BC/day<break/>Total: 6 months</td>
<td valign="top" align="left">Randomized, parallel, placebo-controlled study design.<break/>Placebo: Milk (3.2g/day in capsule form)</td>
<td valign="top" align="left">BC supplementation significantly reduced oxidative stress markers (TBARS) compared to placebo (p&lt;0.01).&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B50">50</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>8 healthy individuals</bold>
</td>
<td valign="top" align="left">10 g placebo +37.5 g Zinc<break/>10 g placebo + 10 g BC<break/>37.5 g Zinc + 10 g BC<break/>10 g placebo + 10 g placebo<break/>Total: 14 days</td>
<td valign="top" align="left">Double-blind, placebo-controlled crossover study design.<break/>Placebo: Isoenergetic and isomacronutrient milk-protein<break/>Concentrate (10g/day + 10g/day in capsule form)</td>
<td valign="top" align="left">Zinc carnosine (ZnC) and colostrum supplementation effectively mitigated the exercise-induced 3-fold increase in gut permeability by 70%.&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B51">51</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>10 healthy individuals</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 14 days</td>
<td valign="top" align="left">Randomized, counterbalanced, placebo-controlled study design.<break/>Placebo: Isocaloric and isomacronutrient 63% skim milk, 37% milk protein (20g/day in powder form)</td>
<td valign="top" align="left">Protected enterocytes in moderate temperatures but not in extreme heat.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B52">52</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>18 healthy individuals</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 14 days</td>
<td valign="top" align="left">Double-blind, placebo-controlled, randomized, crossover study design.<break/>Placebo: Isoenergetic and isomacronutrient milk protein concentrate (20g/day in powder form)</td>
<td valign="top" align="left">Reduced markers of exercise-induced intestinal damage compared to a placebo (191% Placebo to 101% BC).<break/>Lactulose/rhamnose ratio were significantly lower in BC group, as representing the intestinal barrier integrity/permeability (148% to 243%)</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B2">2</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>7 trained individuals</bold>
</td>
<td valign="top" align="left">1.7 g BC/day<break/>Total: 7 days</td>
<td valign="top" align="left">Double-blind, randomized, placebo-controlled crossover study design.<break/>Placebo: Corn flour (1.7g/day in powder form)</td>
<td valign="top" align="left">BC supplementation has no effect on highly trained endurance athletes or untrained individuals</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B53">53</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Adult individuals</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 14 days</td>
<td valign="top" align="left">First study: Randomized, double-blind, placebo-controlled study design.<break/>Second study: Cohort and observational.<break/>Placebo: Maltodextrin (20g/day in powder form)</td>
<td valign="top" align="left">Significant increase in serum IGF-1 (17%) and saliva IgA (33%)&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B1">1</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>10 highly-trained cyclists</bold>
</td>
<td valign="top" align="left">10 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Randomized and controlled study design.<break/>Placebo: Whey protein (10g/day in powder form)</td>
<td valign="top" align="left">Improved cycling performance through the maintenance of testosterone levels and modulation of autonomic activity.</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B3">3</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Healthy individuals</bold>
</td>
<td valign="top" align="left">5 different trials</td>
<td valign="top" align="left">Retrospective study design.</td>
<td valign="top" align="left">Reduction in&#x2003;upper respiratory tract symptoms (URS)&#x2003;in exercising adults (URS days 44%, URS episodes 38%)</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>31 Healthy individuals</bold>
</td>
<td valign="top" align="left">20 g BC/day<break/>Total: 58 days</td>
<td valign="top" align="left">Double-blind, randomized, placebo-controlled study design.<break/>Placebo: isoenergetic/isomacronutrient skimmed milk powder and milk protein concentrate (20g/day in powder form)</td>
<td valign="top" align="left">Enhanced immunity and greater skinfold thickness response in BC group (0.22-0.42 to 0.06-0.16)&#x2003;</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B54">54</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"><bold>40 Healthy individuals</bold>
</td>
<td valign="top" align="left">60 g BC/day<break/>Total: 8 weeks</td>
<td valign="top" align="left">Randomized, double-blind, parallel study design.</td>
<td valign="top" align="left">The colostrum group increased leg press strength from 121 kg to 145 kg (a 19.8% increase), while the whey protein group increased from 143 kg to 151 kg (a 5.6% increase). This represents a 2.8% greater increase for the colostrum group compared to the whey protein group (p = .026).</td>
<td valign="top" align="center">(<xref ref-type="bibr" rid="B55">55</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Cold symptoms that may occur due to sweating and immune suppression after high-effort workouts can lead to a decrease in performance. BC consumption is critical to protect against colds or viral diseases (<xref ref-type="bibr" rid="B56">56</xref>). Because of the Lf it contains, BC not only intervenes in cold symptoms (<xref ref-type="bibr" rid="B57">57</xref>) but also supports the immune system by preventing the proliferation of viruses (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). In the event of a possible disease, Lf support provided by BC consumption increases the response of T-cells by inducing the activity of natural killer cells (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>). In this way, it allows the treatment process to be enhanced. Lactoperoxidase (LPO), an antibacterial enzyme, inhibits bacterial metabolism and exhibits toxicity towards various bacterial types, while also possessing antifungal and antiviral activities (<xref ref-type="bibr" rid="B60">60</xref>). BC, rich in both LPO and Lf concentrations, can strengthen the immune system of athletes and prevent diseases that may cause a decline in their fitness charts.</p>
<p>BC has a richer nutritional value than regular milk (<xref ref-type="bibr" rid="B61">61</xref>). One of these riches is in terms of carbohydrates (<xref ref-type="bibr" rid="B62">62</xref>). Oligosaccharides and conjugated <italic>N</italic>-glycans are also included in this family (<xref ref-type="bibr" rid="B63">63</xref>). These bioactive components have important potential as they are abundant in BC, show prebiotic properties, and provide selective growth in the intestinal microbiota (<xref ref-type="bibr" rid="B24">24</xref>&#x2013;<xref ref-type="bibr" rid="B26">26</xref>) (<xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>). Athletes must maintain their intestinal health, especially those engaging in high levels of physical activity. The prebiotic components contained in BC can prevent possible intestinal diseases by supporting athletes&#x2019; intestinal health. Additionally, these ingredients&#x2019; benefits to the digestive system can increase the efficiency of nutrition programs by allowing athletes to absorb the nutrients they consume more effectively. Therefore, athletes&#x2019; regular consumption of BC may be an important step in protecting intestinal health, ensuring more effective absorption of nutrients. This, in turn, can support athletes&#x2019; overall health and performance and prevent potential gut problems.</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Potential use of colostrum supplementation in sport and therapeutical or supportive effects</title>
<p>Certain compounds of colostrum are highlighted with their activity in gastrointestinal regions. For instance, certain transforming growth factors that are found in the colostrum have potential roles in gastrointestinal diseases (<xref ref-type="bibr" rid="B64">64</xref>). TGF-&#x3b1; can stimulate the secretion of mucin, and enhance regulation of intestinal epithelium by inducing cellular growth and differentiation. TGF-&#x3b2; can also show similar activity to TGF-&#x3b1;. In addition, colostrum can also show anti-inflammatory and antibacterial activity in the region. An <italic>in-vitro</italic> study performed on Caco-2 cells indicated these activities by colostrum (<xref ref-type="bibr" rid="B65">65</xref>). The results investigate the antibacterial activity of colostrum and indicate the potential to reduce bacteria-mediated inflammation by decreasing the increase of IL-8 (to back into the control levels in Caco-2 cells, 1 fold increase to 0.5 fold increase in HT29 cells when compared to control levels). Such findings lead to the discussion of the potential application of colostrum in treating or protecting against potential gastrointestinal damage during exercise.</p>
<p>A double-blind crossover study was performed to investigate the activity of BC in intestinal injury protection from exercise (<xref ref-type="bibr" rid="B41">41</xref>). During the experiment, 12 healthy males consumed BC for 14 days, and certain trials and blood tests were performed. Also researchers have reported that the exercise-based intestinal injury was determined with the levels of 1-FABP, and the result indicated that BC administration was able to slow down the increase of 1-FABP (placebo group was 194% and the colostrum group was 134%). Another study examined the role of BC administration in gut permeability during heavy exercises. 12 participants were involved in a double-blind crossover study and consumed BC for 14 days. The gut permeability test showed that both groups had a similar level of permeability during the start of the study. In the following days of the exercise, BC managed to decrease the permeability increase by nearly 80% (<xref ref-type="bibr" rid="B66">66</xref>).</p>
<p>As discussed, BC can enhance immune regulation and response, anti-pathogenic activity, and protect the gastrointestinal region. As a matter of fact, when these activities are combined, it can potentially lead to a direct positive effect on performance and post-workout recovery (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>) (<xref ref-type="bibr" rid="B66">66</xref>). Another situation that draws attention at this point is the effect of BC consumption on individual performance depending on the consumption of athletes. in a study (<xref ref-type="bibr" rid="B34">34</xref>), a controlled BC consumption of hockey players was recorded and then the results were examined, and the results were reported to significantly increase their sprint and jumping performances (2.3%). Additionally, a similar study showed that BC consumption increases jumping performance and also has a significant effect on anaerobic power (<xref ref-type="bibr" rid="B35">35</xref>).</p>
<p>As for its effects in long-term competitions, it has been observed that the performance of cyclists who were subjected to a 2-hour ride increased significantly in terms of time after controlled BC consumption. Moreover, it is seen that it can affect the mass development in the athletes&#x2019; body by regulating testosterone levels in the body and modulating autonomic activity (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B36">36</xref>). A study investigated the effect of BC consumption on endurance in running performance, recovery, and plasma insulin-like growth factor 1 levels (<xref ref-type="bibr" rid="B35">35</xref>). 51 males performed 8 weeks of running training with two groups; one group consumed 60 g/day BC, and the other group consumed whey powder as a placebo group. The results were significant only for the recovery, as it managed to improve performance (1.5% and 2.3% increase) in the recovery period.</p>
<p>The enhancement on recovery and performance also directly influences muscle gain during the workouts. Since the time of recovery and injury rates are expected to decrease with BC consumption, athletes and sportspersons can enhance their required muscle gain over time by increased performance. Additionally, BC can also directly affect muscle gain, as its components can influence body mass increase positively. For instance, 22 random people were recruited to analyze the effect of BC supplementation on body composition and performance (<xref ref-type="bibr" rid="B10">10</xref>). The participants were divided into two groups; 9 people consumed nearly 20g of BC for 8 weeks, and the rest were placebo. Even though there are slight differences between the two groups in terms of exhaustion from exercise, and performance, the only significant differences were observed in the BC-consumed group&#x2019;s bone-free lean body mass, as the BC-consumed group showed a mean increase of 1.49 kg.</p>
<p>As mentioned in this review article, BC can have various therapeutic effects due to the bioactive elements it contains in a study concluded that BC supplementation increases muscle development in athletes (<xref ref-type="table" rid="T2"><bold>Table&#xa0;2</bold></xref>). From this perspective, it can be used to increase overall muscle mass. One potential compound behind the enhanced muscle gain by BC is IGF-1 since it can help to increase muscle gain by inducing the growth of muscle cells (<xref ref-type="bibr" rid="B67">67</xref>). It has been emphasized that muscle size increases are directly proportional to protein synthesis and degradation, of which IGF-1 is known to be capable of altering these processes (<xref ref-type="bibr" rid="B68">68</xref>). By that, IGF-1 shows primary mechanisms in modulating muscle size and function and is tightly associated with muscular endurance parameters (<xref ref-type="bibr" rid="B69">69</xref>). A recent research investigated the changes in IGF-1 levels in BC supplementation (<xref ref-type="bibr" rid="B70">70</xref>). 90 participants were involved as far as the final analysis, in which half of these participants consumed BC. The serum levels showed that the BC-consumed group had increased levels of IGF-1 (<italic>p = 0.02</italic>). Additionally, the incidence rate of diarrhea was also investigated, which was lower in the BC group (27%) when compared to the control group (47%).</p>
<p>In addition, one of the potential positive effects of BC consumption is that it regulates heart function by increasing IGF-1 levels, affecting stroke volume (14%) and cardiac output (18%) with minimal impact on heart rate and blood pressure (<xref ref-type="bibr" rid="B45">45</xref>). Another benefit that BC consumption can provide to athletes is &#x201c;increasing testosterone levels,&#x201d; which can help athletes achieve more effective results during training and observe positive changes in muscle mass, especially in a short time (<xref ref-type="bibr" rid="B3">3</xref>). In a study conducted on female athletes, it was reported that oxidative stress and inflammation in their bodies decreased (p&lt;0.01), and iron homeostasis in their bodies was positively affected as a result of regular consumption of 3.2g BC daily for 6 months (<xref ref-type="bibr" rid="B50">50</xref>).</p>
</sec>
<sec id="s4" sec-type="conclusions">
<title>Conclusion and future perspectives</title>
<p>This review examined the effects of colostrum on athletes. Clinical studies were conducted, and comparative results were reported. Based on these data, it can be said that colostrum consumption has positive effects on athletes. It has been revealed that it has therapeutic effects with its different bioactive components, especially on disorders caused by different sources such as antiviral, antibacterial, gastrointestinal, and injuries. Thanks to the rich composition of BC, its components can enhance many attributes of the consumer, which makes BC consumption preferred for supplementation in exercise and training. When examined, certain effects of BC are possibly linked together, such as enhancement of performance and recovery, which is also another positive aspect of BC consumption for athletes. Currently, colostrum consumption is increasing, yet not all of its therapeutic effects are fully understood. Further research may uncover new data on this subject, potentially revealing additional effects of colostrum beyond current knowledge. This supportive nutrient, which different audiences as well as athletes can use, stands out with its different effects in different sectors (medical, dermatology, food, etc.). Discovering the potential mechanisms of the bioactive components found in colostrum in the future may encourage its more frequent use in various sectors or the treatment of advanced diseases.</p>
</sec>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>YY: Conceptualization, Visualization, Writing &#x2013; review &amp; editing, Writing &#x2013; original draft. BB: Conceptualization, Writing &#x2013; review &amp; editing. HD: Conceptualization, Visualization, Writing &#x2013; review &amp; editing. FE: Conceptualization, Visualization, Writing &#x2013; review&#xa0;&amp;&#xa0;editing. AB: Writing &#x2013; review &amp; editing. ME: Writing &#x2013; review &amp; editing, Conceptualization. SK: Conceptualization, Supervision, Visualization, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors declare that this study received funding from TUBITAK-TEYDEB #3220901 and Uluova S&#xfc;t Ticaret A.S. (Uluova Milk Trading Co.). The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.</p>
</sec>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>ME and AB are employed by the company Uluova Dairy. SK has received funding from Uluova S&#xfc;t Ticaret A.S (Uluova Milk Trading Co.).</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mero</surname> <given-names>A</given-names>
</name>
<name>
<surname>K&#xe4;hk&#xf6;nen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nyk&#xe4;nen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Parviainen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jokinen</surname> <given-names>I</given-names>
</name>
<name>
<surname>Takala</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training</article-title>. <source>J Appl Physiol (1985)</source>. (<year>2002</year>) <volume>93</volume>:<page-range>732&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/japplphysiol.00002.2002</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>March</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Marchbank</surname> <given-names>T</given-names>
</name>
<name>
<surname>Playford</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Thatcher</surname> <given-names>R</given-names>
</name>
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Intestinal fatty acid-binding protein and gut permeability responses to exercise</article-title>. <source>Eur J Appl Physiol</source>. (<year>2017</year>) <volume>117</volume>:<page-range>931&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00421-017-3582-4</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shing</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Peake</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Coombes</surname> <given-names>JSA</given-names>
</name>
</person-group>. <article-title>Pilot study: bovine colostrum supplementation and hormonal and autonomic responses to competitive cycling</article-title>. <source>J Sports Med Phys Fitness</source>. (<year>2013</year>) <volume>53</volume>:<fpage>490</fpage>&#x2013;<lpage>501</lpage>.</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>AW</given-names>
</name>
<name>
<surname>March</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bridle</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Bovine colostrum supplementation and upper respiratory symptoms during exercise training: A systematic review and meta-analysis of randomised controlled trials</article-title>. <source>BMC Sports Sci Med Rehabil</source>. (<year>2016</year>) <volume>8</volume>:<fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13102-016-0047-8</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Karyelio&#x11f;lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Baydemir</surname> <given-names>B</given-names>
</name>
<name>
<surname>G&#xfc;nar</surname> <given-names>BB</given-names>
</name>
<etal/>
</person-group>. <article-title>Production of bovine colostrum for human consumption to improve health</article-title>. <source>Front Pharmacol</source>. (<year>2022</year>) <volume>12</volume>:<elocation-id>796824</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2021.796824</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#x142;&#xf3;wka</surname> <given-names>N</given-names>
</name>
<name>
<surname>Durkalec-Michalski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wo&#x17a;niewicz</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Immunological outcomes of bovine colostrum supplementation in trained and physically active people: A systematic review and meta-Analysis</article-title>. <source>Nutrients</source>. (<year>2020</year>) <volume>12</volume>:<elocation-id>1023</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12041023</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrientos</surname> <given-names>S</given-names>
</name>
<name>
<surname>Stojadinovic</surname> <given-names>O</given-names>
</name>
<name>
<surname>Golinko</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Brem</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tomic-Canic</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>PERSPECTIVE ARTICLE: growth factors and cytokines in wound healing</article-title>. <source>Wound Repair Regeneration</source>. (<year>2008</year>) <volume>16</volume>:<fpage>585</fpage>&#x2013;<lpage>601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1524-475X.2008.00410.x</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nieman</surname> <given-names>DC</given-names>
</name>
<name>
<surname>Pedersen</surname> <given-names>BK</given-names>
</name>
</person-group>. <article-title>Exercise and immune function</article-title>. <source>Sports Med</source>. (<year>1999</year>) <volume>27</volume>:<fpage>73</fpage>&#x2013;<lpage>80</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2165/00007256-199927020-00001</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwellnus</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sewry</surname> <given-names>N</given-names>
</name>
<name>
<surname>Snyders</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kaulback</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Seocharan</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Symptom cluster is associated with prolonged return-to-play in symptomatic athletes with acute respiratory illness (Including COVID-19): A cross-sectional study&#x2014;AWARE study I</article-title>. <source>Br J Sports Med</source>. (<year>2021</year>) <volume>55</volume>:<page-range>1144&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bjsports-2020-103782</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonio</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sanders</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Van Gammeren</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The effects of bovine colostrum supplementation on body composition and exercise performance in active men and women1</article-title>. <source>Nutrition</source>. (<year>2001</year>) <volume>17</volume>:<page-range>243&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0899-9007(00)00552-9</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skottner</surname> <given-names>A</given-names>
</name>
<name>
<surname>Arrhenius-Nyberg</surname> <given-names>V</given-names>
</name>
<name>
<surname>Kanje</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fryklund</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Anabolic and tissue repair functions of recombinant insulin-like growth factor I</article-title>. <source>Acta Paediatrica</source>. (<year>1990</year>) <volume>79</volume>:<page-range>63&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1651-2227.1990.tb11635.x</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bayraktar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ert&#xfc;rk</surname> <given-names>M</given-names>
</name>
<name>
<surname>Henrick</surname> <given-names>BM</given-names>
</name>
<etal/>
</person-group>. <article-title>Bovine colostrum and its potential for human health and nutrition</article-title>. <source>Front Nutr</source>. (<year>2021</year>) <volume>8</volume>:<elocation-id>651721</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2021.651721</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shing</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Peake</surname> <given-names>J</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Okutsu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>R</given-names>
</name>
<name>
<surname>Stevenson</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of bovine colostrum supplementation on immune variables in highly trained cyclists</article-title>. <source>J Appl Physiol</source>. (<year>2007</year>) <volume>102</volume>:<page-range>1113&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/japplphysiol.00553.2006</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>D</given-names>
</name>
<name>
<surname>Benson</surname> <given-names>KFA</given-names>
</name>
</person-group>. <article-title>Novel extract from bovine colostrum whey supports innate immune functions. II. Rapid changes in cellular immune function in humans</article-title>. <source>Prev Med</source>. (<year>2012</year>) <volume>54</volume>:<page-range>S124&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ypmed.2012.01.004</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginjala</surname> <given-names>V</given-names>
</name>
<name>
<surname>Pakkanen</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Determination of transforming growth factor-B1 (TGF-B1) and insulin-like growth factor 1 (IGF-1) in bovine colostrum samples</article-title>. <source>J Immunoassay</source>. (<year>1998</year>) <volume>19</volume>:<fpage>195</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/01971529808005480</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>T</given-names>
</name>
<name>
<surname>Meletharayil</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kapoor</surname> <given-names>R</given-names>
</name>
<name>
<surname>Abbaspourrad</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Bioactives in bovine milk: chemistry, technology, and applications</article-title>. <source>Nutr Rev</source>. (<year>2021</year>) <volume>79</volume>:<fpage>48</fpage>&#x2013;<lpage>69</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nutrit/nuab099</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Townsend</surname> <given-names>RR</given-names>
</name>
<name>
<surname>McFadden</surname> <given-names>CB</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>V</given-names>
</name>
<name>
<surname>Cad&#xe9;e</surname> <given-names>JAA</given-names>
</name>
</person-group>. <article-title>Randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension*</article-title>. <source>Am J Hypertension</source>. (<year>2004</year>) <volume>17</volume>:<page-range>1056&#x2013;105</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amjhyper.2004.06.018</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>C&#xe1;mara-Martos</surname> <given-names>F</given-names>
</name>
<name>
<surname>Amaro-L&#xf3;pez</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Influence of dietary factors on calcium bioavailability</article-title>. <source>Biol Trace Elem Res</source>. (<year>2002</year>) <volume>89</volume>:<fpage>43</fpage>&#x2013;<lpage>52</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1385/BTER:89:1:43</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scholz-Ahrens</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Schrezenmeir</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Effects of bioactive substances in milk on mineral and trace element metabolism with special reference to casein phosphopeptides</article-title>. <source>Br J Nutr</source>. (<year>2000</year>) <volume>84</volume>:<page-range>147&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0007114500002373</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puddu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Borghi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gessani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Valenti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Belardelli</surname> <given-names>F</given-names>
</name>
<name>
<surname>Seganti</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection</article-title>. <source>Int J Biochem Cell Biol</source>. (<year>1998</year>) <volume>30</volume>:<page-range>1055&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1357-2725(98)00066-1</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolat</surname> <given-names>E</given-names>
</name>
<name>
<surname>Eker</surname> <given-names>F</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sarita&#x15f;</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactoferrin for COVID-19 prevention, treatment, and recovery</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2022.992733</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Selective deglycosylation of lactoferrin to understand glycans&#x2019; Contribution to antimicrobial activity of lactoferrin</article-title>. <source>Cell Mol Biol</source>. (<year>2018</year>) <volume>64</volume>:<page-range>52&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14715/cmb/2018.64.9.8</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Korhonen</surname> <given-names>HJ</given-names>
</name>
</person-group>. <article-title>20 - bioactive milk proteins, peptides and lipids and other functional components derived from milk and bovine colostrum</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Saarela</surname> <given-names>M</given-names>
</name>
</person-group>, editor. <source>Functional Foods</source>, <edition>2nd ed</edition>. <publisher-name>Woodhead Publishing Series in Food Science, Technology and Nutrition</publisher-name>; <publisher-loc>Sawston, United Kingdom</publisher-loc>: <publisher-name>Woodhead Publishing</publisher-name> (<year>2011</year>), ISBN: <isbn>ISBN 978-1-84569-690-0</isbn>. p. <fpage>471</fpage>&#x2013;<lpage>511</lpage>.</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>&#x15e;ahuto&#x11f;lu</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Sar&#x131;ta&#x15f;</surname> <given-names>S</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pekdemir</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of milk glycome in prevention, treatment, and recovery of COVID-19</article-title>. <source>Front Nutr</source>. (<year>2022</year>) <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2022.1033779</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
<name>
<surname>Le Parc</surname> <given-names>A</given-names>
</name>
<name>
<surname>Leite Nobrega de Moura Bell</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Frese</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Kirmiz</surname> <given-names>N</given-names>
</name>
<name>
<surname>Block</surname> <given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>Oligosaccharides released from milk glycoproteins are selective growth substrates for infant-associated bifidobacteria</article-title>. <source>Appl Environ Microbiol</source>. (<year>2016</year>) <volume>82</volume>:<page-range>3622&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.00547-16</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>J.M.L.N.D.M.</given-names>
</name>
<name>
<surname>Parc</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Block</surname> <given-names>DE</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterizing the release of bioactive N-glycans from dairy products by a novel endo-&#x3b2;-N-acetylglucosaminidase</article-title>. <source>Biotechnol Prog</source>. (<year>2015</year>) <volume>31</volume>:<page-range>1331&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/btpr.2135</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tokuyama</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tokuyama</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Purification and identification of TGF-B2-related growth factor from bovine colostrum</article-title>. <source>J Dairy Res</source>. (<year>1993</year>) <volume>60</volume>:<fpage>99</fpage>&#x2013;<lpage>109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0022029900027382</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Morikawa</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Hepatocyte growth factor in human breast milk</article-title>. <source>Am J Reprod Immunol</source>. (<year>1998</year>) <volume>40</volume>:<page-range>112&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0897.1998.tb00399.x</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aparna</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Salimath</surname> <given-names>PV</given-names>
</name>
</person-group>. <article-title>Acidic glycoproteins of buffalo colostrum and their influence on the growth of <italic>Bifidobacterium bifidus</italic>
</article-title>. <source>Nutr Res</source>. (<year>1999</year>) <volume>19</volume>:<fpage>295</fpage>&#x2013;<lpage>303</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0271-5317(98)00192-4</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogawa</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sasahara</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sira</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Futatani</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kanegane</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of transforming growth factor-&#x3b2; in breast milk for initiation of IgA production in newborn infants</article-title>. <source>Early Hum Dev</source>. (<year>2004</year>) <volume>77</volume>:<fpage>67</fpage>&#x2013;<lpage>75</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.earlhumdev.2004.01.005</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Sangild</surname> <given-names>PT</given-names>
</name>
<name>
<surname>&#xd8;stergaard</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Bering</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Chatterton</surname> <given-names>DEW</given-names>
</name>
</person-group>. <article-title>Transforming growth factor-B2 and endotoxin interact to regulate homeostasis via interleukin-8 levels in the immature intestine</article-title>. <source>Am J Physiology-Gastrointestinal Liver Physiol</source>. (<year>2014</year>) <volume>307</volume>:<page-range>G689&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00193.2014</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koyama</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Podolsky</surname> <given-names>DK</given-names>
</name>
</person-group>. <article-title>Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells</article-title>. <source>J Clin Invest</source>. (<year>1989</year>) <volume>83</volume>:<page-range>1768&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI114080</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mero</surname> <given-names>A</given-names>
</name>
<name>
<surname>Miikkulainen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Riski</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pakkanen</surname> <given-names>R</given-names>
</name>
<name>
<surname>Aalto</surname> <given-names>J</given-names>
</name>
<name>
<surname>Takala</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training</article-title>. <source>J Appl Physiol (1985)</source>. (<year>1997</year>) <volume>83</volume>:<page-range>1144&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/jappl.1997.83.4.1144</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofman</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Smeets</surname> <given-names>R</given-names>
</name>
<name>
<surname>Verlaan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Lugt</surname> <given-names>R</given-names>
</name>
<name>
<surname>Verstappen</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>The effect of bovine colostrum supplementation on exercise performance in elite field hockey players</article-title>. <source>Int J Sport Nutr Exercise Metab</source>. (<year>2002</year>) <volume>12</volume>:<page-range>461&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1123/ijsnem.12.4.461</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>BUCKLEY</surname> <given-names>J</given-names>
</name>
<name>
<surname>BRINKWORTH</surname> <given-names>G</given-names>
</name>
<name>
<surname>ABBOTT</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Effect of bovine colostrum on anaerobic exercise performance and plasma insulin-like growth factor I</article-title>. <source>J Sports Sci</source>. (<year>2003</year>) <volume>21</volume>:<page-range>577&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/0264041031000101935</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coombes</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Conacher</surname> <given-names>M</given-names>
</name>
<name>
<surname>Austen</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Marshall</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Dose effects of oral bovine colostrum on physical work capacity in cyclists</article-title>. <source>Med Sci Sports Exerc</source>. (<year>2002</year>) <volume>34</volume>:<page-range>1184&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005768-200207000-00020</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shing</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Stevenson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Coombes</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>The influence of bovine colostrum supplementation on exercise performance in highly trained cyclists</article-title>. <source>Br J Sports Med</source>. (<year>2006</year>) <volume>40</volume>:<fpage>797</fpage>&#x2013;<lpage>801</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bjsm.2006.027946</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinkworth</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Buckley</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Bourdon</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Gulbin</surname> <given-names>JP</given-names>
</name>
<name>
<surname>David</surname> <given-names>AZ</given-names>
</name>
</person-group>. <article-title>Oral bovine colostrum supplementation enhances buffer capacity but not rowing performance in elite female rowers</article-title>. <source>Int J Sport Nutr Exercise Metab</source>. (<year>2002</year>) <volume>12</volume>:<page-range>349&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1123/ijsnem.12.3.349</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ha&#x142;asa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Maciejewska</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ba&#x15b;kiewicz-Ha&#x142;asa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Machali&#x144;ski</surname> <given-names>B</given-names>
</name>
<name>
<surname>Safranow</surname> <given-names>K</given-names>
</name>
<name>
<surname>Stachowska</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Oral supplementation with bovine colostrum decreases intestinal permeability and stool concentrations of zonulin in athletes</article-title>. <source>Nutrients</source>. (<year>2017</year>) <volume>9</volume>:<elocation-id>370</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu9040370</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotsis</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mikellidi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aresti</surname> <given-names>C</given-names>
</name>
<name>
<surname>Persia</surname> <given-names>E</given-names>
</name>
<name>
<surname>Sotiropoulos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Panagiotakos</surname> <given-names>DB</given-names>
</name>
<etal/>
</person-group>. <article-title>Low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a loughborough intermittent shuttle test in soccer players</article-title>. <source>Eur J Nutr</source>. (<year>2018</year>) <volume>57</volume>:<page-range>1181&#x2013;95</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00394-017-1401-7</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>March</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Thatcher</surname> <given-names>R</given-names>
</name>
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The effect of bovine colostrum supplementation on intestinal injury and circulating intestinal bacterial DNA following exercise in the heat</article-title>. <source>Eur J Nutr</source>. (<year>2019</year>) <volume>58</volume>:<page-range>1441&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00394-018-1670-9</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchbank</surname> <given-names>T</given-names>
</name>
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
<name>
<surname>Oakes</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Ghatei</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Patterson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Moyer</surname> <given-names>MP</given-names>
</name>
<etal/>
</person-group>. <article-title>The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes</article-title>. <source>Am J Physiology-Gastrointestinal Liver Physiol</source>. (<year>2011</year>) <volume>300</volume>:<page-range>G477&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00281.2010</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
<name>
<surname>Diment</surname> <given-names>BC</given-names>
</name>
</person-group>. <article-title>Bovine colostrum supplementation attenuates the decrease of salivary lysozyme and enhances the recovery of neutrophil function after prolonged exercise</article-title>. <source>Br J Nutr</source>. (<year>2010</year>) <volume>103</volume>:<page-range>1425&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S0007114509993503</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crooks</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Wall</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Rutherfurd-Markwick</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>The effect of bovine colostrum supplementation on salivary IgA in distance runners</article-title>. <source>Int J Sport Nutr Exercise Metab</source>. (<year>2006</year>) <volume>16</volume>:<fpage>47</fpage>&#x2013;<lpage>64</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1123/ijsnem.16.1.47</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donath</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Jenni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>HP</given-names>
</name>
<name>
<surname>Anrig</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kohli</surname> <given-names>S</given-names>
</name>
<name>
<surname>Glatz</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Cardiovascular and Metabolic Effects of Insulin-like Growth Factor I at Rest and during Exercise in Humans</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>1996</year>) <volume>81</volume>:<page-range>4089&#x2013;94</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jcem.81.11.8923865</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brinkworth</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Buckley</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Slavotinek</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Kurmis</surname> <given-names>AP</given-names>
</name>
</person-group>. <article-title>Effect of bovine colostrum supplementation on the composition of resistance trained and untrained limbs in healthy young men</article-title>. <source>Eur J Appl Physiol</source>. (<year>2004</year>) <volume>91</volume>:<fpage>53</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00421-003-0944-x</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cie&#x15b;licka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stankiewicz</surname> <given-names>B</given-names>
</name>
<name>
<surname>Muszkieta</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tafil-Klawe</surname> <given-names>M</given-names>
</name>
<name>
<surname>Klawe</surname> <given-names>J</given-names>
</name>
<name>
<surname>Skarpa&#x144;ska-Stejnborn</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Long-term bovine colostrum supplementation in football players</article-title>. <source>Nutrients</source>. (<year>2023</year>) <volume>15</volume>:<elocation-id>4779</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu15224779</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skarpa&#x144;ska-Stejnborn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cie&#x15b;licka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dziewiecka</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kujawski</surname> <given-names>S</given-names>
</name>
<name>
<surname>Marcinkiewicz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Trzeciak</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of long-term supplementation of bovine colostrum on the immune system in young female basketball players. Randomized trial</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>118</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13010118</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carol</surname> <given-names>A</given-names>
</name>
<name>
<surname>Witkamp</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Wichers</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Mensink</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Bovine colostrum supplementation&#x2019;s lack of effect on immune variables during short-term intense exercise in well-trained athletes</article-title>. <source>Int J Sport Nutr Exercise Metab</source>. (<year>2011</year>) <volume>21</volume>:<page-range>135&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1123/ijsnem.21.2.135</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cie&#x15b;licka</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ostapiuk-Karolczuk</surname> <given-names>J</given-names>
</name>
<name>
<surname>Buttar</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Dziewiecka</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kasperska</surname> <given-names>A</given-names>
</name>
<name>
<surname>Skarpa&#x144;ska-Stejnborn</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Effects of long-term supplementation of bovine colostrum on iron homeostasis, oxidative stress, and inflammation in female athletes: A placebo-controlled clinical trial</article-title>. <source>Nutrients</source>. (<year>2023</year>) <volume>15</volume>:<elocation-id>186</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu15010186</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
<name>
<surname>Marchbank</surname> <given-names>T</given-names>
</name>
<name>
<surname>March</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Thatcher</surname> <given-names>R</given-names>
</name>
<name>
<surname>Playford</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Zinc carnosine works with bovine colostrum in truncating heavy exercise&#x2013;induced increase in gut permeability in healthy volunteers12</article-title>. <source>Am J Clin Nutr</source>. (<year>2016</year>) <volume>104</volume>:<page-range>526&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3945/ajcn.116.134403</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Berkemeier</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Naylor</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kleint</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gorini</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Bovine colostrum supplementation does not affect plasma I-FABP concentrations following exercise in a hot and humid environment</article-title>. <source>Eur J Appl Physiol</source>. (<year>2017</year>) <volume>117</volume>:<page-range>2561&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00421-017-3743-5</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Cotter</surname> <given-names>JD</given-names>
</name>
</person-group>. <article-title>Bovine colostrum, training status, and gastrointestinal permeability during exercise in the heat: A placebo-controlled double-blind study</article-title>. <source>Appl Physiol Nutr Metab</source>. (<year>2014</year>) <volume>39</volume>:<page-range>1070&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/apnm-2013-0583</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>AW</given-names>
</name>
<name>
<surname>March</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Thatcher</surname> <given-names>R</given-names>
</name>
<name>
<surname>Diment</surname> <given-names>B</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The effects of bovine colostrum supplementation on in vivo immunity following prolonged exercise: A randomised controlled trial</article-title>. <source>Eur J Nutr</source>. (<year>2019</year>) <volume>58</volume>:<page-range>335&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00394-017-1597-6</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duff</surname> <given-names>WRD</given-names>
</name>
<name>
<surname>Chilibeck</surname> <given-names>PD</given-names>
</name>
<name>
<surname>Rooke</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Kaviani</surname> <given-names>M</given-names>
</name>
<name>
<surname>Krentz</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Haines</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>The effect of bovine colostrum supplementation in older adults during resistance training</article-title>. <source>Int J Sport Nutr Exerc Metab</source>. (<year>2014</year>) <volume>24</volume>:<page-range>276&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1123/ijsnem.2013-0182</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Bovine colostrum and its potential contributions for treatment and prevention of COVID-19</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1214514</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
<name>
<surname>German</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Rouqui&#xe9;</surname> <given-names>C</given-names>
</name>
<name>
<surname>Le Parc</surname> <given-names>A</given-names>
</name>
<name>
<surname>Barile</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Studying lactoferrin N-glycosylation</article-title>. <source>Int J Mol Sci</source>. (<year>2017</year>) <volume>18</volume>:<elocation-id>870</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms18040870</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulder</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Connellan</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Oliver</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Stevenson</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males</article-title>. <source>Nutr Res</source>. (<year>2008</year>) <volume>28</volume>:<page-range>583&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nutres.2008.05.007</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Actor</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>S-A</given-names>
</name>
<name>
<surname>Kruzel</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Lactoferrin as a natural immune modulator</article-title>. <source>Curr Pharm Des</source>. (<year>2009</year>) <volume>15</volume>:<page-range>1956&#x2013;73</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/138161209788453202</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikola</surname> <given-names>H</given-names>
</name>
<name>
<surname>Waris</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tenovuo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite</article-title>. <source>Antiviral Res</source>. (<year>1995</year>) <volume>26</volume>:<page-range>161&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0166-3542(94)00073-H</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Uzku&#xe7;</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bayraktar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ert&#xfc;rk</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Determining total protein and bioactive protein concentrations in bovine colostrum</article-title>. <source>J Vis Exp</source>. (<year>2021</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.3791/63001</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duman</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kaplan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arslan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sahutoglu</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Kayili</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Frese</surname> <given-names>SA</given-names>
</name>
<etal/>
</person-group>. <article-title>Potential applications of endo-&#x3b2;-N-acetylglucosaminidases from bifidobacterium longum subspecies infantis in designing value-added, next-generation infant formulas</article-title>. <source>Front Nutr</source>. (<year>2021</year>) <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnut.2021.646275</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Karav</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Application of a novel <italic>endo</italic>-&#x3b2;-<italic>N</italic>-acetylglucosaminidase to isolate an entirely new class of bioactive compounds: <italic>N</italic>-glycans</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Kuddus</surname> <given-names>M</given-names>
</name>
</person-group>, editor. <source>Enzymes in Food Biotechnology</source>. <publisher-loc>Cambridge, Massachusetts, ABD</publisher-loc>: <publisher-name>Academic Press</publisher-name> (<year>2019</year>), ISBN: <isbn>ISBN 978-0-12-813280-7</isbn>. p. <fpage>389</fpage>&#x2013;<lpage>404</lpage>.</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menchetti</surname> <given-names>L</given-names>
</name>
<name>
<surname>Traina</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tomasello</surname> <given-names>G</given-names>
</name>
<name>
<surname>Casagrande-Proietti</surname> <given-names>P</given-names>
</name>
<name>
<surname>Leonardi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Barbato</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Potential benefits of colostrum in gastrointestinal diseases</article-title>. <source>FBS</source>. (<year>2016</year>) <volume>8</volume>:<page-range>331&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2741/S467</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chae</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aitchison</surname> <given-names>A</given-names>
</name>
<name>
<surname>Day</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Keenan</surname> <given-names>JI</given-names>
</name>
</person-group>. <article-title>Bovine colostrum demonstrates anti-inflammatory and antibacterial activity in in vitro models of intestinal inflammation and infection</article-title>. <source>J Funct Foods</source>. (<year>2017</year>) <volume>28</volume>:<page-range>293&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jff.2016.11.016</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davison</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The use of bovine colostrum in sport and exercise</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<elocation-id>1789</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13061789</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehra</surname> <given-names>R</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nayan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Buttar</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Nutritional attributes of bovine colostrum components in human health and disease: A comprehensive review</article-title>. <source>Food Bioscience</source>. (<year>2021</year>) <volume>40</volume>:<elocation-id>100907</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fbio.2021.100907</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Timmer</surname> <given-names>LT</given-names>
</name>
<name>
<surname>Hoogaars</surname> <given-names>WMH</given-names>
</name>
<name>
<surname>Jaspers</surname> <given-names>RT</given-names>
</name>
</person-group>. <article-title>The role of IGF-1 signaling in skeletal muscle atrophy</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Xiao</surname> <given-names>J</given-names>
</name>
</person-group>, editor. <source>Muscle Atrophy</source>. <publisher-name>Springer</publisher-name>, <publisher-loc>Singapore</publisher-loc> (<year>2018</year>), ISBN: <isbn>ISBN 9789811314353</isbn>. p. <page-range>109&#x2013;37</page-range>.</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>T</given-names>
</name>
<name>
<surname>Delafontaine</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy</article-title>. <source>Cells</source>. (<year>2020</year>) <volume>9</volume>:<elocation-id>1970</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9091970</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roohelhami</surname> <given-names>E</given-names>
</name>
<name>
<surname>Vahdat Shariatpanahi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ardehali</surname> <given-names>SH</given-names>
</name>
</person-group>. <article-title>Colostrum supplement, IGF-1, and diarrhea in mechanically-ventilated patients: A double-blind, randomized, placebo-controlled study</article-title>. <source>Nutr Clinique M&#xe9;tabolisme</source>. (<year>2023</year>) <volume>37</volume>:<page-range>227&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.nupar.2023.09.004</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
